Stocks · Health care · Pharmaceutical Preparations

Turn Therapeutics Inc.

TTRX Clue Score40
United States Fiscal year ends December CIK 0002023016 Results filed 12 Aug 2026

What the insiders did No buying or selling

By person

8 insiders · 0 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Abraham Chesed
Board Observer
—
—
—
1,447,268
$5.07M
+1.0%
Arthur F Golden
Director
—
—
—
360,602
$1.26M
—
Bradley Evan Burnam
Chief Executive Officer
—
—
—
300,000
$1.05M
−50.0%
Martin William Dewhurst
Director
—
—
—
21,882
$76.59K
—
Zuraiz Chaudhary
See Remarks
—
—
—
12,500
$43.75K
—
Andrew Gengos
Director
—
—
—
10,000
$35.00K
—
Kent Edward Kester
Director
—
—
—
10,000
$35.00K
—
Neilesh Shailesh Ghodadra
Chief Medical Officer
—
—
—
10,000
$35.00K
—

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.